Back to Search Start Over

Characterization of HealthcareAssociated and CommunityAssociated Clostridioides difficile Infections among Adults, Canada, 2015–2019.

Authors :
Du, Tim
Choi, Kelly B.
Silva, Anada
Golding, George R.
Pelude, Linda
Hizon, Romeo
Al-Rawahi, Ghada N.
Brooks, James
Chow, Blanda
Collet, Jun C.
Comeau, Jeannette L.
Davis, Ian
Evans, Gerald A.
Frenette, Charles
Han, Guanghong
Johnstone, Jennie
Kibsey, Pamela
Katz, Kevin C.
Langley, Joanne M.
Lee, Bonita E.
Source :
Emerging Infectious Diseases; Jun2022, Vol. 28 Issue 6, p1128-1136, 9p
Publication Year :
2022

Abstract

We investigated epidemiologic and molecular characteristics of healthcare-associated (HA) and community-associated (CA) Clostridioides difficile infection (CDI) among adult patients in Canadian Nosocomial Infection Surveillance Program hospitals during 2015–2019. The study encompassed 18,455 CDI cases, 13,735 (74.4%) HA and 4,720 (25.6%) CA. During 2015–2019, HA CDI rates decreased by 23.8%, whereas CA decreased by 18.8%. HA CDI was significantly associated with increased 30-day all-cause mortality as compared with CA CDI (p<0.01). Of 2,506 isolates analyzed, the most common ribotypes (RTs) were RT027, RT106, RT014, and RT020. RT027 was more often associated with CDI-attributable death than was non-RT027, regardless of acquisition type. Overall resistance C. difficile rates were similar for all drugs tested except moxifloxacin. Adult HA and CA CDI rates have declined, coinciding with changes in prevalence of RT027 and RT106. Infection prevention and control and continued national surveillance are integral to clarifying CDI epidemiology, investigation, and control. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10806040
Volume :
28
Issue :
6
Database :
Complementary Index
Journal :
Emerging Infectious Diseases
Publication Type :
Academic Journal
Accession number :
157235627
Full Text :
https://doi.org/10.3201/eid2806.212262